首页 > 最新文献

Journal of Endovascular Therapy最新文献

英文 中文
The "Pre-Rotating Dilator Technique" for Optimal Endograft Orientation in Complex Endovascular Aortic Repair. 预旋转扩张器技术 "在复杂的血管内主动脉修复术中实现了最佳的内移植物定向。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-07-31 DOI: 10.1177/15266028241266218
Angelos Karelis, Björn Sonesson, Nuno V Dias

Purpose: To describe a novel technique for optimal orientation and accurate deployment of aortic endografts during complex endovascular aortic repair (cEVAR).

Technique: After establishing the femoral access in the standard fashion, a long large-bore dilator is inserted before the cEVAR delivery system. The dilator is advanced beyond the renovisceral segment noticing the degree of axial rotation. The endograft markers are verified with fluoroscopy outside the patient in the standard way. Thereafter, the cEVAR delivery system is pre-emptively rotated by the same degree in the opposite direction than the dilator showed upon insertion. The endograft is then advanced into position with the markers ending with the markers roughly in position. Minor adjustments are done before and during deployment if needed as per standard technique.

Conclusion: The use of long, large-bore dilator before the introduction of the aortic graft allows to proactively minimize the risk of endograft misalignment and malrotation especially in cases with challenging anatomies in both the visceral and iliac segments. This can potentially be used in all cases because it minimizes the manipulation of the delivery system and potentially increases the accuracy of endograft deployment.Clinical ImpactThis report describes a novel technique involving the use of a long large-bore dilator to predict the degree of rotation of the cEVAR delivery system during insertion and thereby enabling a pre-emptive compensation. This facilitates the precise orientation of the main aortic endograft with an easier alignment of any branches and/or fenestrations to their respective target arteries. This approach holds the potential to mitigate several of the difficulties commonly encountered with current cEVAR solutions, especially the challenges posed by small and tortuous access and severe angulation in the iliac and visceral aortic segment.

目的:描述一种在复杂主动脉内膜修复术(cEVAR)中对主动脉内膜移植物进行最佳定位和精确部署的新技术:技术:按照标准方式建立股动脉通路后,在 cEVAR 输送系统前插入长的大口径扩张器。将扩张器推进到髂外段之后,注意轴向旋转的程度。按照标准方法,在患者体外通过透视验证内移植物标记。之后,预先将 cEVAR 输送系统向与扩张器插入时相反的方向旋转相同的角度。然后将内膜移植物推进到标记位置,最后标记大致就位。如果需要,可根据标准技术在植入前和植入过程中进行微调:结论:在导入主动脉移植物前使用长、大口径扩张器,可主动将内膜移植物错位和旋转不良的风险降至最低,尤其是在内脏和髂段解剖结构复杂的病例中。这种方法可用于所有病例,因为它最大限度地减少了对输送系统的操作,并有可能提高内移植物部署的准确性:临床影响:本报告介绍了一种新技术,即使用长的大口径扩张器来预测 cEVAR 输送系统在插入过程中的旋转程度,从而实现先发制人的补偿。这有助于主主动脉内移植物的精确定位,并更容易将任何分支和/或瘘管对准各自的目标动脉。这种方法有可能减轻当前 cEVAR 解决方案通常会遇到的一些困难,尤其是髂主动脉和内脏主动脉段狭小、迂曲的入路和严重的成角所带来的挑战。
{"title":"The \"Pre-Rotating Dilator Technique\" for Optimal Endograft Orientation in Complex Endovascular Aortic Repair.","authors":"Angelos Karelis, Björn Sonesson, Nuno V Dias","doi":"10.1177/15266028241266218","DOIUrl":"10.1177/15266028241266218","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a novel technique for optimal orientation and accurate deployment of aortic endografts during complex endovascular aortic repair (cEVAR).</p><p><strong>Technique: </strong>After establishing the femoral access in the standard fashion, a long large-bore dilator is inserted before the cEVAR delivery system. The dilator is advanced beyond the renovisceral segment noticing the degree of axial rotation. The endograft markers are verified with fluoroscopy outside the patient in the standard way. Thereafter, the cEVAR delivery system is pre-emptively rotated by the same degree in the opposite direction than the dilator showed upon insertion. The endograft is then advanced into position with the markers ending with the markers roughly in position. Minor adjustments are done before and during deployment if needed as per standard technique.</p><p><strong>Conclusion: </strong>The use of long, large-bore dilator before the introduction of the aortic graft allows to proactively minimize the risk of endograft misalignment and malrotation especially in cases with challenging anatomies in both the visceral and iliac segments. This can potentially be used in all cases because it minimizes the manipulation of the delivery system and potentially increases the accuracy of endograft deployment.Clinical ImpactThis report describes a novel technique involving the use of a long large-bore dilator to predict the degree of rotation of the cEVAR delivery system during insertion and thereby enabling a pre-emptive compensation. This facilitates the precise orientation of the main aortic endograft with an easier alignment of any branches and/or fenestrations to their respective target arteries. This approach holds the potential to mitigate several of the difficulties commonly encountered with current cEVAR solutions, especially the challenges posed by small and tortuous access and severe angulation in the iliac and visceral aortic segment.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"150-154"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shockwave Intravascular Lithotripsy Use in the Femoro-Popliteal Segment: Considerations From an Expert Pan-European Panel Regarding Best-Care Practice. 股骨-腘绳肌段冲击波血管内碎石术的应用:泛欧专家小组关于最佳护理实践的考虑。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-08-12 DOI: 10.1177/15266028241266417
Athanasios Saratzis, Sarah Jane Messeder, Narayanan Thulasidasan

Purpose: Produce expert recommendations regarding the optimal use of Shockwave intravascular lithotripsy (IVL) when treating femoro-popliteal steno-occlusive peripheral artery disease (PAD), guiding operators to use Shockwave IVL.

Materials and methods: A modified 3-step Delphi process was used to gain consensus surrounding preoperative/intraoperative/postoperative considerations when using Shockwave IVL for femoro-popliteal PAD. This included a structured survey, focus-group (with qualitative thematic analysis of views expressed), and final confirmatory round; participants were recruited across Europe including the United Kingdom/Switzerland.

Results: Following a review to inform an online survey, 25 experts took part in a survey (5 European countries, 2023), followed by a focus-group (15 participants), 9 interviews, and final confirmatory round. A list of recommendations was prepared where at least moderate-level or high-level agreement was reached (≥70% participants agreeing). The recommendations relate to the optimal preoperative imaging, preoperative preparation(s), intraoperative imaging and use of adjuncts, as well as postoperative course, when using Shockwave IVL.

Conclusion: A list of expert recommendations is provided guiding the optimal use of Shockwave IVL in femoro-popliteal PAD. This will help operators achieve better clinical outcomes.Clinical ImpactThis pan-European panel of experts using intravascular lithotripsy in routine peripheral arterial disease endovascular practice has provided important insights into best care practices before, during, and after such procedures. Several recommendations have been produced based on a structured consensus process to guide clinicians globally. This will improve and standardise the use of this technology in the femoro-popliteal arterial segment.

目的:就治疗股腘动脉狭窄闭塞性外周动脉疾病(PAD)时如何最佳使用冲击波血管内碎石术(IVL)提出专家建议,指导操作人员使用冲击波血管内碎石术:采用改良的德尔菲三步法,就使用冲击波IVL治疗股腘动脉PAD时的术前、术中和术后注意事项达成共识。该过程包括结构化调查、焦点小组(对所表达的观点进行定性专题分析)和最后一轮确认;参与者遍布欧洲,包括英国/瑞士:在为网上调查提供信息而进行审查之后,25 名专家参加了调查(5 个欧洲国家,2023 年),随后是焦点小组(15 人参加)、9 次访谈和最后一轮确认。在至少达成中度或高度一致(≥70% 的参与者同意)的情况下,编制了一份建议清单。这些建议涉及使用冲击波 IVL 时的最佳术前成像、术前准备、术中成像和辅助手段的使用以及术后疗程:本文提供了一份专家建议清单,指导如何在股-腘动脉PAD中最佳使用冲击波IVL。这将有助于操作者获得更好的临床效果:这个泛欧专家小组在常规外周动脉疾病血管内治疗中使用血管内碎石术,为此类手术前、手术中和手术后的最佳护理实践提供了重要见解。基于结构化的共识过程,他们提出了多项建议,为全球临床医生提供指导。这将改进和规范该技术在股-腘动脉段的使用。
{"title":"Shockwave Intravascular Lithotripsy Use in the Femoro-Popliteal Segment: Considerations From an Expert Pan-European Panel Regarding Best-Care Practice.","authors":"Athanasios Saratzis, Sarah Jane Messeder, Narayanan Thulasidasan","doi":"10.1177/15266028241266417","DOIUrl":"10.1177/15266028241266417","url":null,"abstract":"<p><strong>Purpose: </strong>Produce expert recommendations regarding the optimal use of Shockwave intravascular lithotripsy (IVL) when treating femoro-popliteal steno-occlusive peripheral artery disease (PAD), guiding operators to use Shockwave IVL.</p><p><strong>Materials and methods: </strong>A modified 3-step Delphi process was used to gain consensus surrounding preoperative/intraoperative/postoperative considerations when using Shockwave IVL for femoro-popliteal PAD. This included a structured survey, focus-group (with qualitative thematic analysis of views expressed), and final confirmatory round; participants were recruited across Europe including the United Kingdom/Switzerland.</p><p><strong>Results: </strong>Following a review to inform an online survey, 25 experts took part in a survey (5 European countries, 2023), followed by a focus-group (15 participants), 9 interviews, and final confirmatory round. A list of recommendations was prepared where at least moderate-level or high-level agreement was reached (≥70% participants agreeing). The recommendations relate to the optimal preoperative imaging, preoperative preparation(s), intraoperative imaging and use of adjuncts, as well as postoperative course, when using Shockwave IVL.</p><p><strong>Conclusion: </strong>A list of expert recommendations is provided guiding the optimal use of Shockwave IVL in femoro-popliteal PAD. This will help operators achieve better clinical outcomes.Clinical ImpactThis pan-European panel of experts using intravascular lithotripsy in routine peripheral arterial disease endovascular practice has provided important insights into best care practices before, during, and after such procedures. Several recommendations have been produced based on a structured consensus process to guide clinicians globally. This will improve and standardise the use of this technology in the femoro-popliteal arterial segment.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"128-137"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12804419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Center Experience on the Elective Hybrid Combination of Single Perclose + Angio-Seal VIP 8F Compared With Standard Dual Perclose During Percutaneous Endovascular Aortic Aneurysm Repair. 经皮血管内主动脉瘤修补术中选择性混合使用单层包扎+Angio-Seal VIP 8F 与标准双层包扎的单中心经验比较。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-07-31 DOI: 10.1177/15266028241266182
Paolo Spath, Filippo Maioli, Federica Campana, Teresa Gabellini, Annalisa Perulli, Michele Leone, Francesco Giacchi, Giacomo Di Iasio, Massimiliano Marini, Silvia Massini, Sara Pomatto, Cecilia Angherà, Salvatore Tarantini
<p><strong>Purpose: </strong>This single-center study aimed to assess patients who underwent intentional percutaneous endovascular aortic aneurysm repair (pEVAR) with Hybrid Technique combining a single Perclose (Abbott, Abbott Park, Illinois) Suture-Mediated Closure Device + single Angio-Seal VIP 8F (Terumo, Tokyo, Japan) and compare outcomes with the standard Dual Perclose technique.</p><p><strong>Materials and methods: </strong>Consecutive elective pEVAR patients treated from November 2022 to November 2023, with healthy femoral accesses and introducer sheaths ≤20 French (F) outer diameter, were included. Coin-toss randomization determined whether a combination of single Perclose Device + single Angio-Seal VIP 8F (Hybrid Technique) or the standard double Perclose Devices (Dual Perclose) was used. In Hybrid Technique, a single Perclose device was positioned at 12 o'clock; a single Angio-Seal VIP 8F was placed after sheaths removal. Dual Perclose followed standard procedure. Primary endpoints included immediate hemostasis, sheath diameter differences, access conversion rate, technical success, and cost analysis.</p><p><strong>Results: </strong>The study involved 60 pEVAR patients (median age=78, interquartile range [IQR]=72-85 years) within the inclusion criteria. In 14 (24%) cases, only 1 femoral access was studied. There were 106 pEVAR accesses, with 58 (54.7%) in the Hybrid Technique group and 48 (45.3%) in the Dual Perclose group. Both groups exhibited homogeneity in pre-operative characteristics and sheath diameter (Hybrid Technique-16F vs Dual Perclose-18F; p=0.202). Immediate hemostasis was achieved in 100% of the Hybrid Technique group vs 87.5% for the Dual Perclose group (p=0.006). Surgical access conversion was unnecessary. Technical success was 100%, with all 6 femoral bleeding cases after Dual Perclose resolved endovascularly, using additional devices. Cost analysis showed a median cost of 330 euros (IQR=0) for the Hybrid Technique group vs 384 euros (IQR=360-456) for the Dual Perclose group (p<0.001). Thirty-day mortality was 3%, in 2 fragile patients, without access-related complications. Multivariate analysis identified Dual Perclose access (odds ratio [OR]=35.6; 95% confidence interval [CI]=18.3-36.8; p<0.001) and obesity (OR=19.7; 95% CI=1.4-23.9.5; p<0.001) as independent risk factors for immediate hemostasis failure. Median follow-up was 134 days (IQR=41-227), with 1 Hybrid Technique case (2%) successfully treated with thrombin injection for a small femoral pseudoaneurysm after 62 days.</p><p><strong>Conclusions: </strong>The elective Hybrid Technique with combination of single Perclose Device + single Angio-Seal VIP 8F during pEVAR in selected patients appears to be non-inferior to the standard Dual Perclose procedure. It demonstrates a positive trend in reducing immediate hemostasis failure and costs. Both procedures achieved technical success and avoiding surgical access conversions.Clinical ImpactThis study introduces a nov
目的:本单中心研究旨在评估采用混合技术(结合单个 Perclose(Abbott,伊利诺伊州雅培公园)缝合介导闭合装置 + 单个 Angio-Seal VIP 8F(Terumo,日本东京))进行有意经皮血管内主动脉瘤修补术(pEVAR)的患者,并将结果与标准双 Perclose 技术进行比较。材料和方法:纳入2022年11月至2023年11月期间接受治疗的连续择期pEVAR患者,其股骨通路健康,导引鞘外径≤20 French (F)。双掷随机决定是使用单个Perclose装置+单个Angio-Seal VIP 8F(混合技术),还是使用标准的双Perclose装置(双Perclose)。在混合技术中,单个 Perclose 装置放置在 12 点钟位置;单个 Angio-Seal VIP 8F 则在取鞘后放置。Dual Perclose 遵循标准程序。主要终点包括即时止血、鞘直径差异、入路转换率、技术成功率和成本分析:研究涉及 60 名符合纳入标准的 pEVAR 患者(中位年龄=78 岁,四分位数间距 [IQR] =72-85 岁)。其中有 14 例(24%)只研究了 1 条股动脉通路。共有 106 个 pEVAR 入路,其中 58 个(54.7%)在混合技术组,48 个(45.3%)在双层包膜组。两组在术前特征和鞘管直径(混合技术-16F vs 双层包封-18F;P=0.202)方面具有同质性。混合技术组 100%实现立即止血,而双层包膜组为 87.5%(P=0.006)。无需进行手术入路转换。技术成功率为100%,所有6例股骨出血病例在使用双环闭后均通过血管内治疗解决,并使用了额外的装置。成本分析显示,混合技术组的中位成本为330欧元(IQR=0),而双闭合术组的中位成本为384欧元(IQR=360-456)(P结论:在对选定患者进行 pEVAR 时,结合使用单个 Perclose 装置 + 单个 Angio-Seal VIP 8F 的选择性混合技术似乎并不比标准的双 Perclose 手术差。它在减少即时止血失败和成本方面显示出积极的趋势。两种手术都取得了技术成功,避免了手术入路转换:本研究介绍了一种新颖的选择性混合技术,它将单个 Perclose 装置与单个 Angio-Seal VIP 8Fr 结合在一起,用于经皮腔内主动脉介入治疗。混合技术的结果显示,技术成功率为100%,并能立即有效止血,而成本却低于标准的双Perclose手术。两种手术都不需要手术转换。尽管这是一项单中心研究,但它证明了有意应用这种混合技术实现微创的潜在好处。肥胖和双Perclose技术被确定为止血失败的独立风险因素,再次证实了混合技术手术的有效性以及与标准手术相比的非劣势。
{"title":"Single-Center Experience on the Elective Hybrid Combination of Single Perclose + Angio-Seal VIP 8F Compared With Standard Dual Perclose During Percutaneous Endovascular Aortic Aneurysm Repair.","authors":"Paolo Spath, Filippo Maioli, Federica Campana, Teresa Gabellini, Annalisa Perulli, Michele Leone, Francesco Giacchi, Giacomo Di Iasio, Massimiliano Marini, Silvia Massini, Sara Pomatto, Cecilia Angherà, Salvatore Tarantini","doi":"10.1177/15266028241266182","DOIUrl":"10.1177/15266028241266182","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;This single-center study aimed to assess patients who underwent intentional percutaneous endovascular aortic aneurysm repair (pEVAR) with Hybrid Technique combining a single Perclose (Abbott, Abbott Park, Illinois) Suture-Mediated Closure Device + single Angio-Seal VIP 8F (Terumo, Tokyo, Japan) and compare outcomes with the standard Dual Perclose technique.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;Consecutive elective pEVAR patients treated from November 2022 to November 2023, with healthy femoral accesses and introducer sheaths ≤20 French (F) outer diameter, were included. Coin-toss randomization determined whether a combination of single Perclose Device + single Angio-Seal VIP 8F (Hybrid Technique) or the standard double Perclose Devices (Dual Perclose) was used. In Hybrid Technique, a single Perclose device was positioned at 12 o'clock; a single Angio-Seal VIP 8F was placed after sheaths removal. Dual Perclose followed standard procedure. Primary endpoints included immediate hemostasis, sheath diameter differences, access conversion rate, technical success, and cost analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The study involved 60 pEVAR patients (median age=78, interquartile range [IQR]=72-85 years) within the inclusion criteria. In 14 (24%) cases, only 1 femoral access was studied. There were 106 pEVAR accesses, with 58 (54.7%) in the Hybrid Technique group and 48 (45.3%) in the Dual Perclose group. Both groups exhibited homogeneity in pre-operative characteristics and sheath diameter (Hybrid Technique-16F vs Dual Perclose-18F; p=0.202). Immediate hemostasis was achieved in 100% of the Hybrid Technique group vs 87.5% for the Dual Perclose group (p=0.006). Surgical access conversion was unnecessary. Technical success was 100%, with all 6 femoral bleeding cases after Dual Perclose resolved endovascularly, using additional devices. Cost analysis showed a median cost of 330 euros (IQR=0) for the Hybrid Technique group vs 384 euros (IQR=360-456) for the Dual Perclose group (p&lt;0.001). Thirty-day mortality was 3%, in 2 fragile patients, without access-related complications. Multivariate analysis identified Dual Perclose access (odds ratio [OR]=35.6; 95% confidence interval [CI]=18.3-36.8; p&lt;0.001) and obesity (OR=19.7; 95% CI=1.4-23.9.5; p&lt;0.001) as independent risk factors for immediate hemostasis failure. Median follow-up was 134 days (IQR=41-227), with 1 Hybrid Technique case (2%) successfully treated with thrombin injection for a small femoral pseudoaneurysm after 62 days.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The elective Hybrid Technique with combination of single Perclose Device + single Angio-Seal VIP 8F during pEVAR in selected patients appears to be non-inferior to the standard Dual Perclose procedure. It demonstrates a positive trend in reducing immediate hemostasis failure and costs. Both procedures achieved technical success and avoiding surgical access conversions.Clinical ImpactThis study introduces a nov","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"482-493"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Sonographic Parameters for Predicting Primary Patency Rate in Hemodialysis Patients With Venous Valve-Related Stenosis. 评估用于预测静脉瓣膜狭窄血液透析患者初次通畅率的超声参数
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-08-15 DOI: 10.1177/15266028241270680
Yu Xiong, Xuejing Gao, Lin Cui, Qiong Lyu, Bo Tu, Bo Chen, Ziming Wan

Objectives: Ultrasonography is more frequently used in patients with arteriovenous fistula (AVF) stenosis. The aim of this study is to use sonographic parameters for predicting primary patency in hemodialysis patients with venous valve-related stenosis (VVRS) who are treated by ultrasound-guided percutaneous transluminal angioplasty (PTA).

Methods: A total of 229 VVRS patients who underwent PTA between January 2017 and December 2021 were enrolled. Clinical characteristics were retrospectively collected. Sonographic parameters were measured both before and after PTA. Univariate and multivariate Cox analyses were performed to identify independent factors associated with primary patency rate.

Results: All measured sonographic parameters improved after PTA compared to before PTA. Before PTA, the diameter of VVRS > 1.0 mm, age ≤ 57 years, and body mass index (BMI) > 21.57 kg/m2 were associated with better outcomes. While the diameter of radial artery, proximal radial artery close to the anastomosis, brachial artery, the flow volume of brachial artery, the length and peak velocity (PV) of the VVRS, and the diameter and PV after the VVRS had no association with the primary patency rate. After PTA, only patients with a diameter of VVRS > 4.0 mm had favorable outcome. In addition, patients with a gain of diameter of VVRS > 2.4 mm after PTA had a trend of better outcomes.

Conclusions: The diameter of VVRS before and after PTA could be served as markers to predict primary patency rate and second patency rate in AVF patients with VVRS. The gain of diameter of VVRS could also be a potential marker.Clinical ImpactUsing simple markers of sonographic parameters, we could quickly identify patients with a higher risk of restenosis. These patients should be followed more closely in case of restenosis at early. It is also beneficial to the prevention of thrombosis. These measures help to preserve more valuable vascular for a long-term dialysis. Additionally, the physician should pay more attention on the dialysis-related complications in these risky patients, such as hemodialysis-related hypotension.

目的:超声波检查在动静脉瘘(AVF)狭窄患者中应用较多。本研究旨在利用超声参数预测接受超声引导下经皮腔内血管成形术(PTA)治疗的静脉瓣膜相关狭窄(VVRS)血液透析患者的一次通畅率:共纳入了 229 名在 2017 年 1 月至 2021 年 12 月期间接受 PTA 治疗的 VVRS 患者。回顾性收集临床特征。PTA前后均测量了声像图参数。进行了单变量和多变量Cox分析,以确定与一次通畅率相关的独立因素:结果:与PTA前相比,PTA后所有测量的声像图参数均有所改善。PTA前,VVRS直径大于1.0 mm、年龄小于57岁、体重指数(BMI)大于21.57 kg/m2与更好的预后相关。而桡动脉、靠近吻合口的桡动脉近端、肱动脉的直径、肱动脉的血流量、VVRS的长度和峰值速度(PV)以及VVRS后的直径和PV与一次通畅率没有关系。PTA 后,只有 VVRS 直径大于 4.0 mm 的患者预后良好。此外,PTA 后 VVRS 直径增大 > 2.4 mm 的患者有好转的趋势:结论:PTA前后的VVRS直径可作为预测VVRS动静脉瘘患者一次通畅率和二次通畅率的指标。临床影响:临床影响:利用简单的声像图参数标记,我们可以快速识别出再狭窄风险较高的患者。临床影响:利用简单的声学参数标记物,我们可以快速识别出再狭窄风险较高的患者,并对这些患者进行更密切的随访,以防再狭窄的早期发生。这也有利于预防血栓形成。这些措施有助于为长期透析保留更多宝贵的血管。此外,医生应更加关注这些高危患者的透析相关并发症,如血液透析相关低血压。
{"title":"Assessment of Sonographic Parameters for Predicting Primary Patency Rate in Hemodialysis Patients With Venous Valve-Related Stenosis.","authors":"Yu Xiong, Xuejing Gao, Lin Cui, Qiong Lyu, Bo Tu, Bo Chen, Ziming Wan","doi":"10.1177/15266028241270680","DOIUrl":"10.1177/15266028241270680","url":null,"abstract":"<p><strong>Objectives: </strong>Ultrasonography is more frequently used in patients with arteriovenous fistula (AVF) stenosis. The aim of this study is to use sonographic parameters for predicting primary patency in hemodialysis patients with venous valve-related stenosis (VVRS) who are treated by ultrasound-guided percutaneous transluminal angioplasty (PTA).</p><p><strong>Methods: </strong>A total of 229 VVRS patients who underwent PTA between January 2017 and December 2021 were enrolled. Clinical characteristics were retrospectively collected. Sonographic parameters were measured both before and after PTA. Univariate and multivariate Cox analyses were performed to identify independent factors associated with primary patency rate.</p><p><strong>Results: </strong>All measured sonographic parameters improved after PTA compared to before PTA. Before PTA, the diameter of VVRS > 1.0 mm, age ≤ 57 years, and body mass index (BMI) > 21.57 kg/m<sup>2</sup> were associated with better outcomes. While the diameter of radial artery, proximal radial artery close to the anastomosis, brachial artery, the flow volume of brachial artery, the length and peak velocity (PV) of the VVRS, and the diameter and PV after the VVRS had no association with the primary patency rate. After PTA, only patients with a diameter of VVRS > 4.0 mm had favorable outcome. In addition, patients with a gain of diameter of VVRS > 2.4 mm after PTA had a trend of better outcomes.</p><p><strong>Conclusions: </strong>The diameter of VVRS before and after PTA could be served as markers to predict primary patency rate and second patency rate in AVF patients with VVRS. The gain of diameter of VVRS could also be a potential marker.Clinical ImpactUsing simple markers of sonographic parameters, we could quickly identify patients with a higher risk of restenosis. These patients should be followed more closely in case of restenosis at early. It is also beneficial to the prevention of thrombosis. These measures help to preserve more valuable vascular for a long-term dialysis. Additionally, the physician should pay more attention on the dialysis-related complications in these risky patients, such as hemodialysis-related hypotension.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"453-461"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periaortitis Secondary to Evar: Case Report and Literature Review. 继发于埃瓦尔的大动脉周围炎:病例报告和文献综述
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-05-22 DOI: 10.1177/15266028241255528
M Massara, V Alberti, G Restifo, A Alberti, P Volpe

Periaortitis post endovascular aortic aneurysm repair (EVAR) represents a very rare complication, described only in 10 cases between 2001 and 2023. It may appear early or late after EVAR and the majority of patients had ureter compression, and all patients were treated with high dose of corticosteroids, with a complete resolution of symptoms except for one patient. We report a literature review and a case of early post-EVAR periaortitis manifested with acute renal failure due to ureter compression, treated with urgent bilateral J stent and high dose of corticosteroid, with complete resolution of symptoms.Clinical ImpactEven if periaortitis secondary to EVAR is a very rare complication, it is important for the surgeon to know this possible rare complication and its characteristics, in order to immediately recognize it and treat it adequately to avoid complications.

临床影响:尽管 EVAR 继发的大动脉周围炎是一种非常罕见的并发症,但外科医生必须了解这种可能的罕见并发症及其特征,以便立即识别并适当治疗,避免并发症的发生。
{"title":"Periaortitis Secondary to Evar: Case Report and Literature Review.","authors":"M Massara, V Alberti, G Restifo, A Alberti, P Volpe","doi":"10.1177/15266028241255528","DOIUrl":"10.1177/15266028241255528","url":null,"abstract":"<p><p>Periaortitis post endovascular aortic aneurysm repair (EVAR) represents a very rare complication, described only in 10 cases between 2001 and 2023. It may appear early or late after EVAR and the majority of patients had ureter compression, and all patients were treated with high dose of corticosteroids, with a complete resolution of symptoms except for one patient. We report a literature review and a case of early post-EVAR periaortitis manifested with acute renal failure due to ureter compression, treated with urgent bilateral J stent and high dose of corticosteroid, with complete resolution of symptoms.Clinical ImpactEven if periaortitis secondary to EVAR is a very rare complication, it is important for the surgeon to know this possible rare complication and its characteristics, in order to immediately recognize it and treat it adequately to avoid complications.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"351-357"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uterine Artery Embolization Versus Hysterectomy in Postpartum Hemorrhage: A Systematic Review With Meta-Analysis. 子宫动脉栓塞术与子宫切除术治疗产后出血:带 Meta 分析的系统回顾。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-05-11 DOI: 10.1177/15266028241252730
Miguel Godeiro Fernandez, Sarah Fernandez Coutinho de Carvalho, Bruna Almeida Martins, Felipe da Silva Mota Santos, Fernando Antonio Falcão Paixão Neto, Malu Oliveira de Araujo Medeiros, Patrick Bastos Metzger

Purpose: The objective of this study is to perform a meta-analysis comparing the effectiveness of uterine artery embolization (UAE) versus peripartum hysterectomy for acute refractory postpartum hemorrhage (PPH) control.

Materials and methods: We systematically searched 6 medical databases for studies comparing UAE and hysterectomy in PPH. Outcomes examined were mortality, hospitalization duration (HD) in days, and red blood cells (RBC) units utilization. Statistical analysis used RevMan 5.1.7 and random-effects models. Odds ratios (OR) and mean differences (MDs) with 95% confidence intervals (CIs) were used for dichotomous and continuous outcomes, respectively.

Results: We included 833 patients from 4 cohort studies, with 583 (70%) undergoing UAE. The UAE population required fewer RBC units (MD: -7.39; 95% CI: -14.73 to -0.04; p=0.05) and had shorter HD (MD: -3.22; 95% CI: -5.42 to -1.02; p=0.004). Lower mortality rates were noted for UAE in the pooled analysis, but no statistical significance. Uterine artery embolization demonstrated lower procedural complications (16.45% vs. 28.8%), in which UAE had less ureter and bladder lesions (OR: 0.05; 95% CI: 0.01-0.38; p=0.004 and OR: 0.02; 95% CI: 0.00-0.15; p<0.001, respectively). Only 35 (6%) required conversion to hysterectomy, while 27 (4.6%) underwent re-embolization with 100% bleeding control. Uterine artery embolization did not hinder fertility, with normal menstruation restored in 19 patients with postoligomenorrhea.

Conclusion: Uterine artery embolization for the control of PPH is associated with lower use of RBC units and HD, but similar rates of mortality are noted when compared to hysterectomy. These results associated with uterine preservation could support its importance for refractory PPH management.Clinical ImpactUterine Artery Embolization is associated with a shorter hospitalization duration and reduced use of red blood cell units when compared with hysterectomy in refractory postpartum hemorrhage. Although demonstrating similar mortality rates, these findings, together with fertility preservation, support the method incorporation as a valuable option in obstetric services.

目的:本研究旨在进行一项荟萃分析,比较子宫动脉栓塞术(UAE)与围产期子宫切除术在控制急性难治性产后出血(PPH)方面的有效性:我们对 6 个医学数据库进行了系统检索,比较了 UAE 和子宫切除术在 PPH 中的应用。研究结果包括死亡率、住院时间(HD)(天数)和红细胞(RBC)使用量。统计分析使用 RevMan 5.1.7 和随机效应模型。对于二分结果和连续结果,分别使用了带 95% 置信区间的比值比 (OR) 和平均差 (MD):我们纳入了来自 4 项队列研究的 833 名患者,其中 583 人(70%)接受了 UAE 治疗。UAE人群需要的RBC单位更少(MD:-7.39;95% CI:-14.73至-0.04;P=0.05),HD时间更短(MD:-3.22;95% CI:-5.42至-1.02;P=0.004)。在汇总分析中,UAE的死亡率较低,但无统计学意义。子宫动脉栓塞术的手术并发症较低(16.45% vs. 28.8%),其中UAE的输尿管和膀胱病变较少(OR:0.05;95% CI:0.01-0.38;p=0.004;OR:0.02;95% CI:0.00-0.15;p):子宫动脉栓塞控制PPH与较少使用RBC单位和HD有关,但与子宫切除术相比,死亡率相似。这些与保留子宫相关的结果支持了其在难治性 PPH 治疗中的重要性:临床影响:与子宫切除术相比,子宫动脉栓塞术治疗难治性产后出血的住院时间更短,红细胞单位使用量更少。虽然死亡率相似,但这些研究结果以及生育力的保留都支持将该方法作为产科服务的重要选择。
{"title":"Uterine Artery Embolization Versus Hysterectomy in Postpartum Hemorrhage: A Systematic Review With Meta-Analysis.","authors":"Miguel Godeiro Fernandez, Sarah Fernandez Coutinho de Carvalho, Bruna Almeida Martins, Felipe da Silva Mota Santos, Fernando Antonio Falcão Paixão Neto, Malu Oliveira de Araujo Medeiros, Patrick Bastos Metzger","doi":"10.1177/15266028241252730","DOIUrl":"10.1177/15266028241252730","url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study is to perform a meta-analysis comparing the effectiveness of uterine artery embolization (UAE) versus peripartum hysterectomy for acute refractory postpartum hemorrhage (PPH) control.</p><p><strong>Materials and methods: </strong>We systematically searched 6 medical databases for studies comparing UAE and hysterectomy in PPH. Outcomes examined were mortality, hospitalization duration (HD) in days, and red blood cells (RBC) units utilization. Statistical analysis used RevMan 5.1.7 and random-effects models. Odds ratios (OR) and mean differences (MDs) with 95% confidence intervals (CIs) were used for dichotomous and continuous outcomes, respectively.</p><p><strong>Results: </strong>We included 833 patients from 4 cohort studies, with 583 (70%) undergoing UAE. The UAE population required fewer RBC units (MD: -7.39; 95% CI: -14.73 to -0.04; p=0.05) and had shorter HD (MD: -3.22; 95% CI: -5.42 to -1.02; p=0.004). Lower mortality rates were noted for UAE in the pooled analysis, but no statistical significance. Uterine artery embolization demonstrated lower procedural complications (16.45% vs. 28.8%), in which UAE had less ureter and bladder lesions (OR: 0.05; 95% CI: 0.01-0.38; p=0.004 and OR: 0.02; 95% CI: 0.00-0.15; <i>p</i><0.001, respectively). Only 35 (6%) required conversion to hysterectomy, while 27 (4.6%) underwent re-embolization with 100% bleeding control. Uterine artery embolization did not hinder fertility, with normal menstruation restored in 19 patients with postoligomenorrhea.</p><p><strong>Conclusion: </strong>Uterine artery embolization for the control of PPH is associated with lower use of RBC units and HD, but similar rates of mortality are noted when compared to hysterectomy. These results associated with uterine preservation could support its importance for refractory PPH management.Clinical ImpactUterine Artery Embolization is associated with a shorter hospitalization duration and reduced use of red blood cell units when compared with hysterectomy in refractory postpartum hemorrhage. Although demonstrating similar mortality rates, these findings, together with fertility preservation, support the method incorporation as a valuable option in obstetric services.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"78-87"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140909517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antithrombotic Therapy and Freedom From Bridging Stent Occlusion After Elective Branched Endovascular Repair: A Multicenter International Cohort Study. 抗血栓治疗与选择性分支血管内修复术后桥接支架闭塞的发生率:一项多中心国际队列研究。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-05-26 DOI: 10.1177/15266028241253133
Vaiva Dabravolskaite, Lorenz Meuli, Ozan Yazar, Lee Bouwmann, Hozan Mufty, Geert Maleux, Pekka Aho, Harri Hakovirta, Maarit Venermo, Vladimir Makaloski

The risk of bridging stent occlusion after branched endovascular aortic repair (BEVAR) remains an issue. Currently, there is no clear recommendation on what kind of antithrombotic therapy should be installed after BEVAR. The aim of the study was to estimate the impact of postoperative antithrombotic therapy on bridging stent occlusion rate after elective BEVAR. An international multicenter retrospective analysis was performed in 4 European tertiary vascular units. All reno-visceral target vessels treated with bridging stents of patients undergoing elective BEVAR with the use of off-the-shelf or custom-made branched stent-grafts for pararenal aortic aneurysms (PAAs), type Ia endoleaks after previous EVAR, and thoracoabdominal aortic aneurysms (TAAA) between January 2014 and December 2022 were included. Primary outcome was freedom from bridging stent occlusion and its correlation with postoperative antithrombotic therapy. Secondary outcomes were overall survival and identifying target vessel and bridging stent characteristics, which may have a higher risk for bridging stent occlusion according to the PRINCE2SS recommendation. Follow-up information was obtained for all patients per 31st of December 2022. In total, 120 patients (90 male) with a median age of 72 (interquartile range [IQR]=67-77) years were included. Two hundred eighty-nine external and 127 internal branches were used for 416 target vessels. The median follow-up was 21 months (IQR=9-48) with a follow-up index of 1.0. During follow-up, 24 (5.8%) primary bridging stent occlusions (left renal artery [LRA]=10, right renal artery [RRA]=7, superior mesenteric artery [SMA]=3, truncus coeliacus [TC]=4) were found. The risk of renal bridging stent occlusion is significantly higher compared with visceral bridging stent, p=0.013. The occlusion rate was 7.8% for renal branches and 1.5% for visceral branches at 1 year and 10.6% and 3.7% at 5 years, respectively. The multivariable Cox proportional hazard model on bridging stent occlusion showed that there was no significant difference between the used antithrombotic strategies. No antithrombotic therapy was significantly associated with bridging stent occlusion, whereas no evidence for superiority of any other antithrombotic therapy was found. Overall, the bridging stents' occlusion rate was low. We found a significantly higher occlusion rate in renal arteries compared with the visceral ones.Clinical ImpactBased on our study, no antithrombotic therapy is significantly associated with bridging stent occlusion, and no evidence of the superiority of other antithrombotic therapy exists. Nevertehless, due to the low number of bridging stent occlusions, this study can neither support nor reject the PRINCE2SS recommendations. Further studies with larger cohorts are needed to determine clear guideliness of the best antithrombotic treatment regimen after complex enfovascular aortic repair.

临床影响:根据我们的研究,没有一种抗血栓疗法与桥接支架闭塞有明显相关性,也没有证据表明其他抗血栓疗法具有优越性。尽管如此,由于桥接支架闭塞的数量较少,本研究既不能支持也不能拒绝 PRINCE2SS 的建议。要明确复杂主动脉腔内修复术后最佳抗血栓治疗方案的指导意义,还需要进行更大规模的队列研究。
{"title":"Antithrombotic Therapy and Freedom From Bridging Stent Occlusion After Elective Branched Endovascular Repair: A Multicenter International Cohort Study.","authors":"Vaiva Dabravolskaite, Lorenz Meuli, Ozan Yazar, Lee Bouwmann, Hozan Mufty, Geert Maleux, Pekka Aho, Harri Hakovirta, Maarit Venermo, Vladimir Makaloski","doi":"10.1177/15266028241253133","DOIUrl":"10.1177/15266028241253133","url":null,"abstract":"<p><p>The risk of bridging stent occlusion after branched endovascular aortic repair (BEVAR) remains an issue. Currently, there is no clear recommendation on what kind of antithrombotic therapy should be installed after BEVAR. The aim of the study was to estimate the impact of postoperative antithrombotic therapy on bridging stent occlusion rate after elective BEVAR. An international multicenter retrospective analysis was performed in 4 European tertiary vascular units. All reno-visceral target vessels treated with bridging stents of patients undergoing elective BEVAR with the use of off-the-shelf or custom-made branched stent-grafts for pararenal aortic aneurysms (PAAs), type Ia endoleaks after previous EVAR, and thoracoabdominal aortic aneurysms (TAAA) between January 2014 and December 2022 were included. Primary outcome was freedom from bridging stent occlusion and its correlation with postoperative antithrombotic therapy. Secondary outcomes were overall survival and identifying target vessel and bridging stent characteristics, which may have a higher risk for bridging stent occlusion according to the PRINCE2SS recommendation. Follow-up information was obtained for all patients per 31st of December 2022. In total, 120 patients (90 male) with a median age of 72 (interquartile range [IQR]=67-77) years were included. Two hundred eighty-nine external and 127 internal branches were used for 416 target vessels. The median follow-up was 21 months (IQR=9-48) with a follow-up index of 1.0. During follow-up, 24 (5.8%) primary bridging stent occlusions (left renal artery [LRA]=10, right renal artery [RRA]=7, superior mesenteric artery [SMA]=3, truncus coeliacus [TC]=4) were found. The risk of renal bridging stent occlusion is significantly higher compared with visceral bridging stent, p=0.013. The occlusion rate was 7.8% for renal branches and 1.5% for visceral branches at 1 year and 10.6% and 3.7% at 5 years, respectively. The multivariable Cox proportional hazard model on bridging stent occlusion showed that there was no significant difference between the used antithrombotic strategies. No antithrombotic therapy was significantly associated with bridging stent occlusion, whereas no evidence for superiority of any other antithrombotic therapy was found. Overall, the bridging stents' occlusion rate was low. We found a significantly higher occlusion rate in renal arteries compared with the visceral ones.Clinical ImpactBased on our study, no antithrombotic therapy is significantly associated with bridging stent occlusion, and no evidence of the superiority of other antithrombotic therapy exists. Nevertehless, due to the low number of bridging stent occlusions, this study can neither support nor reject the PRINCE2SS recommendations. Further studies with larger cohorts are needed to determine clear guideliness of the best antithrombotic treatment regimen after complex enfovascular aortic repair.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"276-284"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12804412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Embolization for Idiopathic Serial Right Internal Mammary Artery Aneurysms. 血管内栓塞治疗特发性连续右乳内动脉瘤
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-06-03 DOI: 10.1177/15266028241256521
Kaige Deng, Yiyun Xie, Jiang Shao, Zhichao Lai, Yongchang Zheng, Bao Liu

Clinical ImpactThis article showed images of a patient with idiopathic serial right internal mammary artery true aneurysms treated by endovascular embolization, which is a rare diagnosis and should be considered in differential diagnosis of paratracheal mass.

临床图像:本文展示了一名特发性连续性右乳内动脉真性动脉瘤患者通过血管内栓塞治疗后的图像,这是一种罕见的诊断,应在气管旁肿块的鉴别诊断中予以考虑。
{"title":"Endovascular Embolization for Idiopathic Serial Right Internal Mammary Artery Aneurysms.","authors":"Kaige Deng, Yiyun Xie, Jiang Shao, Zhichao Lai, Yongchang Zheng, Bao Liu","doi":"10.1177/15266028241256521","DOIUrl":"10.1177/15266028241256521","url":null,"abstract":"<p><p>Clinical ImpactThis article showed images of a patient with idiopathic serial right internal mammary artery true aneurysms treated by endovascular embolization, which is a rare diagnosis and should be considered in differential diagnosis of paratracheal mass.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"35-37"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Experience of the Covered Endovascular Reconstruction of Iliac Bifurcation Technique. 髂分叉覆盖式血管内重建技术的初步经验
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-05-30 DOI: 10.1177/15266028241256507
Miltiadis Matsagkas, Konstantinos Spanos, Athanasios Haidoulis, George Kouvelos, Konstantinos Dakis, Elena Arnaoutoglou, Athanasios Giannoukas

Introduction: The distal landing zone in iliac arteries represents an important issue during endovascular repair of abdominal aortic aneurysms (EVAR). The aim of this study is to present a case series for landing in the external iliac artery (EIA) during EVAR while preserving blood flow in the internal iliac artery (IIA) with the covered endovascular reconstruction of the iliac bifurcation (CERIB) technique.

Methods: This is a single-center, retrospective analysis of prospectively collected data of patients that underwent EVAR either for intact abdominal aortic aneurysm (AAA) or previous failed EVAR from December 2022 up to September 2023. Indications for treatment were presence of common iliac artery aneurysm (CIAA), short CIA, or endoleak type Ib (ETIb). For the distal sealing zone, we used balloon-expandable covered stent (BXCS). Primary outcomes were technical success and first-month patency rate. Secondary outcomes were endoleak and re-intervention rate.

Results: Sixteen patients being treated with 20 CERIBs were included in the study. Four patients had a previous failed EVAR, while 3 patients were treated urgently for a symptomatic para-renal aneurysm. The indications for treatment were EIb (n=2), short CIA (n=4), CIAA with narrow lumen (n=3), and CIA aneurysm (n=11). Platforms that were used were the Cook Zenith Alpha (n=5), Gore C3 (n=2 and 3 limbs), Endurant IIs (n=2, and 3 limbs), and a t-branch device (n=3). Technical success rate was 100% with no adjunctive procedure. No death or re-intervention was recorded for all patients at postoperative 30-day period and at 6 months for 2 patients. At first-month CTA, patency rate was 100% (20/20), while in 2 patients that had 6-month CTA, the patency was also 100% (2/2). No kinking or stenosis was also noted. Two patients had ETIII after branched EVAR (BEVAR), 2 patients had ETII, and 1 patient had gutter ET in the area of the CERIB.

Conclusion: The CERIB technique seems to be effective and safe in the early period. It is suitable with a variety of commercial endograft platforms. It may be a valuable alternative to iliac branch devices when there are anatomical considerations. Longer follow-up is needed to conclude for long-term patency and durability.Clinical ImpactThe distal landing zone in iliac arteries represents an important issue during EVAR while it is important to preserve blood flow in the internal iliac artery. The covered endovascular reconstruction of the iliac bifurcation (CERIB) technique is a technique for the preservation of internal iliac arteries during EVAR, while it is suitable with a variety of commercial endograft platforms. The CERIB technique seems to be effective and safe in the early period. It may be valuable alternative to iliac branch devices when there are anatomical considerations.

导言:髂动脉远端着床区是腹主动脉瘤(EVAR)血管内修复术中的一个重要问题。本研究旨在通过髂骨分叉处覆盖式血管内重建(CERIB)技术,介绍在 EVAR 过程中髂外动脉(EIA)着床,同时保留髂内动脉(IIA)血流的系列病例:这是对2022年12月至2023年9月期间因完整腹主动脉瘤(AAA)或既往EVAR失败而接受EVAR的患者的前瞻性数据进行的单中心回顾性分析。治疗指征为存在髂总动脉瘤(CIAA)、短CIA或Ib型内漏(ESTIb)。对于远端密封区,我们使用了球囊扩张覆盖支架(BXCS)。主要结果是技术成功率和首月通畅率。次要结果为内漏和再次介入率:16名患者接受了20个CERIB的治疗。结果:16 名患者接受了 20 个 CERIBs 的治疗,其中 4 名患者曾有过 EVAR 失败的经历,3 名患者因有症状的肾旁动脉瘤而接受了紧急治疗。治疗适应症为EIb(2例)、短CIA(4例)、管腔狭窄的CIAA(3例)和CIA动脉瘤(11例)。使用的平台有:Cook Zenith Alpha(5 个)、Gore C3(2 个和 3 个肢体)、Endurant IIs(2 个和 3 个肢体)以及 t 型分支装置(3 个)。在没有辅助手术的情况下,技术成功率为 100%。所有患者在术后 30 天内无死亡记录,2 名患者在术后 6 个月内无死亡记录。在第一个月的CTA检查中,通畅率为100%(20/20),而在进行6个月CTA检查的2名患者中,通畅率也是100%(2/2)。也没有发现扭结或狭窄。两名患者在分支EVAR(BEVAR)术后出现了ETIII,两名患者出现了ETII,一名患者在CERIB区域出现了水沟ET:结论:CERIB技术在早期似乎有效且安全。结论:CERIB 技术在早期似乎有效且安全,适用于各种商业内植物移植平台。如果有解剖学方面的考虑,它可能是髂支装置的一个有价值的替代选择。临床影响:临床影响:髂动脉的远端着床区是 EVAR 期间的一个重要问题,同时保留髂内动脉的血流也很重要。髂骨分叉有盖血管内重建(CERIB)技术是一种在EVAR过程中保留髂内动脉的技术,适用于各种商业内植物平台。CERIB 技术在早期似乎是有效和安全的。在有解剖学考虑的情况下,它可能是髂支装置的重要替代方案。
{"title":"Initial Experience of the Covered Endovascular Reconstruction of Iliac Bifurcation Technique.","authors":"Miltiadis Matsagkas, Konstantinos Spanos, Athanasios Haidoulis, George Kouvelos, Konstantinos Dakis, Elena Arnaoutoglou, Athanasios Giannoukas","doi":"10.1177/15266028241256507","DOIUrl":"10.1177/15266028241256507","url":null,"abstract":"<p><strong>Introduction: </strong>The distal landing zone in iliac arteries represents an important issue during endovascular repair of abdominal aortic aneurysms (EVAR). The aim of this study is to present a case series for landing in the external iliac artery (EIA) during EVAR while preserving blood flow in the internal iliac artery (IIA) with the covered endovascular reconstruction of the iliac bifurcation (CERIB) technique.</p><p><strong>Methods: </strong>This is a single-center, retrospective analysis of prospectively collected data of patients that underwent EVAR either for intact abdominal aortic aneurysm (AAA) or previous failed EVAR from December 2022 up to September 2023. Indications for treatment were presence of common iliac artery aneurysm (CIAA), short CIA, or endoleak type Ib (ETIb). For the distal sealing zone, we used balloon-expandable covered stent (BXCS). Primary outcomes were technical success and first-month patency rate. Secondary outcomes were endoleak and re-intervention rate.</p><p><strong>Results: </strong>Sixteen patients being treated with 20 CERIBs were included in the study. Four patients had a previous failed EVAR, while 3 patients were treated urgently for a symptomatic para-renal aneurysm. The indications for treatment were EIb (n=2), short CIA (n=4), CIAA with narrow lumen (n=3), and CIA aneurysm (n=11). Platforms that were used were the Cook Zenith Alpha (n=5), Gore C3 (n=2 and 3 limbs), Endurant IIs (n=2, and 3 limbs), and a t-branch device (n=3). Technical success rate was 100% with no adjunctive procedure. No death or re-intervention was recorded for all patients at postoperative 30-day period and at 6 months for 2 patients. At first-month CTA, patency rate was 100% (20/20), while in 2 patients that had 6-month CTA, the patency was also 100% (2/2). No kinking or stenosis was also noted. Two patients had ETIII after branched EVAR (BEVAR), 2 patients had ETII, and 1 patient had gutter ET in the area of the CERIB.</p><p><strong>Conclusion: </strong>The CERIB technique seems to be effective and safe in the early period. It is suitable with a variety of commercial endograft platforms. It may be a valuable alternative to iliac branch devices when there are anatomical considerations. Longer follow-up is needed to conclude for long-term patency and durability.Clinical ImpactThe distal landing zone in iliac arteries represents an important issue during EVAR while it is important to preserve blood flow in the internal iliac artery. The covered endovascular reconstruction of the iliac bifurcation (CERIB) technique is a technique for the preservation of internal iliac arteries during EVAR, while it is suitable with a variety of commercial endograft platforms. The CERIB technique seems to be effective and safe in the early period. It may be valuable alternative to iliac branch devices when there are anatomical considerations.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"316-324"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141176325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-term Outcomes of Image-Guided Surgical Thromboembolectomy and Routine Intraoperative Angiography for Native Vessel Acute Lower-Limb-Threatening Ischemia. 图像引导下血栓栓塞切除术和常规术中血管造影术治疗原生血管急性下肢危重缺血的中期疗效。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2024-06-02 DOI: 10.1177/15266028241255544
Ashraf Gamal Taha, Kerolos R Basta, Mohammed Shahat, Ahmed Khairy Sayed Ahmed
<p><strong>Background: </strong>Standard balloon-catheter thromboembolectomy (TE) is an established effective treatment for acute lower-limb ischemia (ALI) with recognized limitations when there is an underlying arterial lesion or thromboembolism of the infrapopliteal arteries. The aim of this study was to evaluate the efficacy and safety of image-guided surgical TE combined with routine intraoperative completion angiography in the treatment of ALI patients.</p><p><strong>Methods: </strong>Between September 2020 and August 2022, this prospective study included all consecutive adult patients presenting to a tertiary center with unilateral ALI of Rutherford class II due to thromboembolic occlusion of native arteries who underwent image-guided surgical TE and routine completion intraoperative angiography. Adjunctive endovascular techniques (hybrid revascularization) including plain balloon angioplasty (PTA)±stenting or on-table lysis were used if underlying arterial lesions or residual thrombosis were detected on the intraoperative angiography, respectively. The primary outcome measures included technical success and 30-day major amputation rate. Perioperative complications, 1-year primary and secondary patency, limb salvage, mortality, and amputation-free survival rates were endorsed as secondary outcome measures.</p><p><strong>Results: </strong>Image-guided surgical thrombectomy was done for 109 ALI patients (109 limbs), provisionally diagnosed as embolic (57 patients, 52.3%) or thrombotic (52 patients, 47.7%) arterial occlusion. Thromboembolectomy without adjunctive endovascular treatment was done in 38 patients (34.86%), whereas 71 patients (65.14%) required adjunctive PTA±stenting of underlying arterial lesions (60, 55.05%) or on-table lysis±PTA of residual thrombosis (11, 10.09%). The overall technical success rate was 92.66%. At 30 days, amputation and mortality rates were 3.67% and 5.5%, respectively. None of the patients had thrombectomy-induced arterial injuries. One-year follow-up data were available for 81 patients (74.3%). The Kaplan-Meier estimate of the 12-month primary and secondary patency, limb salvage, and amputation-free survival rates was 76.5%±0.04, 91.5%±0.03, 90.6±0.03, and 91.4±0.03%, respectively.</p><p><strong>Conclusions: </strong>Image-guided TE combined with routine intraoperative angiography is a safe and effective technique for surgical TE in acute lower-limb ischemia patients with the advantage of immediate identification and treatment of underlying arterial lesions or residual thrombosis for optimal revascularization.Clinical ImpactThe present study has confirmed the safety and effectiveness of image-guided thromboembolectomy combined with routine use of intraoperative angiography during surgical treatment of acute lower limb ischemia in terms of immediate identification and treatment of underlying arterial lesions or residual thrombosis for optimal revascularization. This technique also facilitates selective passag
背景:标准的球囊导管血栓栓塞切除术(TE)是治疗急性下肢缺血(ALI)的有效方法,但当存在潜在的动脉病变或膝下动脉血栓栓塞时,TE的局限性已得到公认。本研究旨在评估图像引导手术 TE 结合常规术中完成血管造影治疗 ALI 患者的有效性和安全性:2020年9月至2022年8月期间,这项前瞻性研究纳入了所有因血栓栓塞闭塞原生动脉导致单侧卢瑟福II级ALI而前往三级中心就诊并接受图像引导手术TE和常规术中完成血管造影的连续成年患者。如果在术中血管造影中发现潜在动脉病变或残余血栓,则分别采用辅助血管内技术(混合血管再通),包括普通球囊血管成形术(PTA)±支架植入术或台上溶栓术。主要结果指标包括技术成功率和30天主要截肢率。围手术期并发症、1年主要和次要通畅率、肢体挽救率、死亡率和无截肢生存率作为次要结果指标:109例ALI患者(109条肢体)在图像引导下接受了手术血栓切除术,初步诊断为栓塞性(57例患者,52.3%)或血栓性(52例患者,47.7%)动脉闭塞。38名患者(34.86%)在未辅助血管内治疗的情况下进行了血栓栓塞切除术,而71名患者(65.14%)需要辅助PTA±支架植入术治疗潜在的动脉病变(60名,55.05%)或在台上溶栓±PTA治疗残余血栓(11名,10.09%)。总体技术成功率为 92.66%。30天后,截肢率和死亡率分别为3.67%和5.5%。没有一名患者因血栓切除术导致动脉损伤。81名患者(74.3%)获得了一年的随访数据。12个月主要和次要通畅率、肢体挽救率和无截肢生存率的卡普兰-梅耶估计值分别为76.5%±0.04、91.5%±0.03、90.6±0.03和91.4±0.03%:图像引导下的TE结合常规术中血管造影是一种安全有效的技术,适用于急性下肢缺血患者的外科TE,其优势在于可立即识别和治疗潜在的动脉病变或残余血栓,以实现最佳的血管再通:本研究证实,在急性下肢缺血的手术治疗过程中,图像引导下的血栓栓塞切除术与术中血管造影术的常规应用既安全又有效,可立即识别和治疗潜在的动脉病变或残余血栓,以实现最佳的血管再通。这项技术还有助于选择性地将 Fogarty 球囊导管从股动脉进入腘下动脉,而传统的做法是在区域或全身麻醉下探查腘三叉动脉或胫骨动脉。使用这种技术可以指导手术外科医生对球囊进行适当的操作和充气,以避免先天性血管损伤。
{"title":"Mid-term Outcomes of Image-Guided Surgical Thromboembolectomy and Routine Intraoperative Angiography for Native Vessel Acute Lower-Limb-Threatening Ischemia.","authors":"Ashraf Gamal Taha, Kerolos R Basta, Mohammed Shahat, Ahmed Khairy Sayed Ahmed","doi":"10.1177/15266028241255544","DOIUrl":"10.1177/15266028241255544","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Standard balloon-catheter thromboembolectomy (TE) is an established effective treatment for acute lower-limb ischemia (ALI) with recognized limitations when there is an underlying arterial lesion or thromboembolism of the infrapopliteal arteries. The aim of this study was to evaluate the efficacy and safety of image-guided surgical TE combined with routine intraoperative completion angiography in the treatment of ALI patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Between September 2020 and August 2022, this prospective study included all consecutive adult patients presenting to a tertiary center with unilateral ALI of Rutherford class II due to thromboembolic occlusion of native arteries who underwent image-guided surgical TE and routine completion intraoperative angiography. Adjunctive endovascular techniques (hybrid revascularization) including plain balloon angioplasty (PTA)±stenting or on-table lysis were used if underlying arterial lesions or residual thrombosis were detected on the intraoperative angiography, respectively. The primary outcome measures included technical success and 30-day major amputation rate. Perioperative complications, 1-year primary and secondary patency, limb salvage, mortality, and amputation-free survival rates were endorsed as secondary outcome measures.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Image-guided surgical thrombectomy was done for 109 ALI patients (109 limbs), provisionally diagnosed as embolic (57 patients, 52.3%) or thrombotic (52 patients, 47.7%) arterial occlusion. Thromboembolectomy without adjunctive endovascular treatment was done in 38 patients (34.86%), whereas 71 patients (65.14%) required adjunctive PTA±stenting of underlying arterial lesions (60, 55.05%) or on-table lysis±PTA of residual thrombosis (11, 10.09%). The overall technical success rate was 92.66%. At 30 days, amputation and mortality rates were 3.67% and 5.5%, respectively. None of the patients had thrombectomy-induced arterial injuries. One-year follow-up data were available for 81 patients (74.3%). The Kaplan-Meier estimate of the 12-month primary and secondary patency, limb salvage, and amputation-free survival rates was 76.5%±0.04, 91.5%±0.03, 90.6±0.03, and 91.4±0.03%, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Image-guided TE combined with routine intraoperative angiography is a safe and effective technique for surgical TE in acute lower-limb ischemia patients with the advantage of immediate identification and treatment of underlying arterial lesions or residual thrombosis for optimal revascularization.Clinical ImpactThe present study has confirmed the safety and effectiveness of image-guided thromboembolectomy combined with routine use of intraoperative angiography during surgical treatment of acute lower limb ischemia in terms of immediate identification and treatment of underlying arterial lesions or residual thrombosis for optimal revascularization. This technique also facilitates selective passag","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"341-350"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Endovascular Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1